TVTX vs TXN · rev $296.8M vs P/E 52, rev $10.29B
Travere Therapeutics Inc (TVTX) versus Texas Instruments Incorporated (TXN) — a side-by-side from cached financials, not a winner call.
Travere Therapeutics Inc (TVTX) is a biotechnology company listed on US.
Texas Instruments Incorporated (TXN) is a semiconductors company listed on NASDAQ.
Latest reported TVTX revenue for 2026-06-30 was $296.8M. Net income was -$71.9M. TVTX currently screens at market cap $1.33B.
Latest reported TXN revenue for 2026-06-30 was $10.29B. Net income was $3.52B. TXN currently screens at market cap $274.74B and trailing P/E 51.7.
TVTX currently screens at market cap $1.33B. TXN currently screens at market cap $274.74B and trailing P/E 51.7.
Not investment advice. Open the TVTX and TXN stock pages for the full models.
Not investment advice.